From: Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review
Reference | Biomarker | Patient Population | N (%)* | Grading of fibrosis on biopsy | Time from biomarker evaluation to biopsy | Correlation Coefficient | AUC/Specificity/Sensitivity |
---|---|---|---|---|---|---|---|
Correlation Coefficient r >0.40 or AUC >0.65 | |||||||
El Ghoul et al [14] | Urine PIIINP | Biopsies for clinical reasons | 118 | Banff 2003/ Semi-quantitatively | Within 1 month | r = 0.32 p < 0.001 | NR |
Teppo et al [15] | Urine PIIINP | Transplant recipients | 79 | Banff 1997/ Semi-quantitatively | Same timea | r = 0.41 p < 0.001 | To predict no fibrosis urine PIIINP <100 ng/mmol NR/84%/83% |
Soylemezoglu et al [16] | Urine and blood PIIINP | Biopsies for clinical reasons | 40 | Morphometric analysis | Same time | Urine PIIINP r = 0.51 p < 0.01 Blood PIIINP r = 0.49 p < 0.01 | NR |
Honkanen et al [20] | Urine TGF- β | Idiopathic membranous glomeruloneph-ritis | 27 | Semi-quantitatively | Same time and 1 year prior to biopsyb | r = 0.29 p = 0.2 (same time) r = 0.86 p = 0.01 (1 year prior) | NR |
Susianti et al [21] | Urine TGF- β | Lupus nephritis | 58(76) | Semi-quantitatively | Same time | r = 0.60 p < 0.001 | 0.90/85%/84% |
Murakami et al [22] | Urine TGF-β | Glomerulopat-hy | 42 | Semi-quantitatively | Same time | NR | NR |
Zhang et al [24] | Urine MCP-1 Urine Hepcidin Urine LFABP | Lupus nephritis | 61 | Semi-quantitatively | Within 24Â h | NR NR NR | 0.66/59%/65% |
0.48/93%/35% | |||||||
0.60/85%/41% | |||||||
Chang et al [25] | Blood PAI-1 | Transplant recipients | 50 | CADI score | Same time | r = 0.41 p = 0.003 | NR |
Sanders et al [26] | Urine MMP-2 Urine TIMP-1 | ANCA vasculitis | 29 | Semi-quantitatively | Same time | Urine MMP-2 r = 0.41 p = 0.02 Urine TIMP-1 r = 0.35 p = 0.05 | NR |
Correlation Coefficient r ≤0.40 and AUC ≤0.65 | |||||||
Grenzi et al [18] | Blood CD30 | Transplant Recipients | 511(25) | Banff 2007 | 10Â days to 9.8Â years | NR | NR |
Amer et al [10] | Urine RBP | Transplant recipients | 221(36) | Banff 1997 | Same time | r = 0.20 p = 0.003 | NR |
Barbosa de Deus et al [11] | Urine RBP | Glomerulopa-thy | 100 | Image digitalization | Same time | NR | NR |
Pallet et al [12] | Urine RBP | Biopsies for clinical reasons | 162 | Numerical quantification software | Same time | r = 0.33 p = 0.001 | Fibrosis score > 25% NR/95%/20% |
Zhu et al [13] | Blood VCAM-1 | IgA nephropathy | 327(23) | Oxford classification | Same time | NR | NR |
Metalidis et al [17] | Urine CTGF | Transplant recipients | 3151 225 | Banff 1997 | Same time and 21 months apart | NR | Same time AUC = 0.63 21 months: AUC = 0.65 |
Liu et al [19] | Urine MBL | IgA nephropathy | 162 | Lee’s classification/ Oxford classification | Same time | NR | NR |
Lu et al [23] | Urine SGK-1 | IgA nephropathy | 76 | Oxford classification | Same time | r = 0.24 p = 0.04 (adjusted for M)c r = 0.37 p = 0.001 (adjusted for E)c r = 0.34 p = 0.003 (adjusted for S)c | NR |